Literature DB >> 22046848

Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003.

C Brooke Steele1, Maria Pisu, Lisa C Richardson.   

Abstract

BACKGROUND: Receipt of treatment for lung cancer varies by a number of demographic factors, including race/ethnicity and urban/rural residence. We examined urban/rural patterns in receipt of treatment for non-mall cell lung cancer (NSCLC) (ie, surgery, chemotherapy, radiation therapy) among black and white Medicare beneficiaries in Alabama.
METHODS: After linking Alabama State Cancer Registry data with state Medicare data, we identified 3481 cases of stages I to IV and unknown-stage NSCLC diagnosed from 2000-2002 and obtained their treatment data for 1999-2003. We used bivariate and multivariate analyses to examine racial and urban/rural differences in receipt of treatment. Significant bivariate associations were tested using chi2 tests.
RESULTS: Among beneficiaries with resectable NSCLC (ie, stages I-IIIA), urban whites were more likely to undergo surgical resection than urban blacks (49.3% vs 33.0%, respectively), and more rural whites than rural blacks (49.8% vs 23.9%, respectively) underwent surgery. There was less variation by race and urban/rural residence in the receipt of chemotherapy and radiation therapy. After controlling for age at diagnosis, gender, stage at diagnosis, comorbidity score, and socioeconomic status, the racial disparity for surgery remained. Black beneficiaries in urban counties had 45% lower odds of undergoing surgery than urban white beneficiaries (OR, 0.55; 95% CI, 0.31-0.96), and those in rural counties had 67% lower odds of receiving this treatment than their white counterparts (OR, 0.33; 95% CI, 0.19-0.57).
CONCLUSIONS: Differences in receipt of surgery exist for both urban and rural black Alabamians with NSCLC. Future studies should explore access to care and perceptions about treatment among lung cancer patients in this state.

Entities:  

Mesh:

Year:  2011        PMID: 22046848     DOI: 10.1016/s0027-9684(15)30410-7

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  16 in total

1.  Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.

Authors:  B Ashleigh Guadagnolo; Kai-Ping Liao; Linda Elting; Sharon Giordano; Thomas A Buchholz; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

2.  Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.

Authors:  Norma E Farrow; Selena J An; Paul J Speicher; David H Harpole; Thomas A D'Amico; Jacob A Klapper; Matthew G Hartwig; Betty C Tong
Journal:  J Thorac Cardiovasc Surg       Date:  2019-11-13       Impact factor: 5.209

3.  Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.

Authors:  Matthew B Schabath; Douglas Cress; Teresita Munoz-Antonia
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

4.  Rural versus urban differences in end-of-life care for lung cancer patients in Germany.

Authors:  Julia Walter; Amanda Tufman; Reiner Leidl; Rolf Holle; Larissa Schwarzkopf
Journal:  Support Care Cancer       Date:  2018-02-04       Impact factor: 3.603

5.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

6.  Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.

Authors:  Xinwei Hua; Kevin C Ward; Theresa W Gillespie; Joseph Lipscomb; Michael Goodman
Journal:  J Community Health       Date:  2014-08

7.  Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.

Authors:  Abbie Begnaud; Ping Yang; Camille Robichaux; Nathan Rubin; Robert Kratzke; Anne Melzer; Constantin Aliferis; Pamala Jacobson
Journal:  Clin Lung Cancer       Date:  2019-10-30       Impact factor: 4.785

8.  Cultural factors associated with racial disparities in lung cancer care.

Authors:  Jenny J Lin; Grace Mhango; Melanie M Wall; Linda Lurslurchachai; Keosha T Bond; Judith E Nelson; Andrew R Berman; John Salazar-Schicchi; Charles Powell; Steven M Keller; Ethan A Halm; Howard Leventhal; Juan P Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2014-05

9.  Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care?

Authors:  Jeannette Y Lee; Page C Moore; Matthew A Steliga
Journal:  Med Care       Date:  2013-12       Impact factor: 2.983

10.  Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States.

Authors:  B Ashleigh Guadagnolo; Jinhai Huo; Kai-Ping Liao; Thomas A Buchholz; Prajnan Das
Journal:  Cancer       Date:  2012-11-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.